33.99 USD
-1.2 (-3.41%)
33.8166 USD
-0.17 (-0.51%)
ChartMill assigns a Buy % Consensus number of 85% to TVTX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 42.33. This target is 24.54% above the current price.
TVTX was analyzed by 21 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about TVTX.
In the previous month the buy percentage consensus was at a similar level.
TVTX was analyzed by 21 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-11-04 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-10-31 | TD Cowen | Maintains | Buy -> Buy |
| 2025-09-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-09-12 | Stifel | Maintains | Hold -> Hold |
| 2025-09-11 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-09-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-09-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-08-28 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-08-07 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2025-08-07 | Wedbush | Maintains | Outperform -> Outperform |
| 2025-06-11 | Citigroup | Maintains | Buy -> Buy |
| 2025-05-16 | Wedbush | Reiterate | Outperform -> Outperform |
| 2025-05-02 | Stifel | Maintains | Hold -> Hold |
| 2025-05-02 | Wedbush | Reiterate | Outperform -> Outperform |
| 2025-04-23 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-04-14 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-04-10 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-04-03 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-04-01 | B of A Securities | Maintains | Buy -> Buy |
| 2025-02-26 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-02-24 | Citigroup | Maintains | Buy -> Buy |
| 2025-02-21 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-02-12 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2025-02-12 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-02-12 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-01-15 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-11-14 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2024-11-01 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2024-11-01 | Barclays | Maintains | Overweight -> Overweight |
TRAVERE THERAPEUTICS INC / TVTX FAQ
What is the price target for TVTX stock?
21 analysts have analysed TVTX and the average price target is 42.33 USD. This implies a price increase of 24.54% is expected in the next year compared to the current price of 33.99.
What is the consensus rating for TRAVERE THERAPEUTICS INC (TVTX) stock?
The consensus rating for TRAVERE THERAPEUTICS INC (TVTX) is 84.7619 / 100 . This indicates that analysts generally have a positive outlook on the stock.